Biovica has strengthened the company’s presence in the United States by adding Edward M. (Ted) Suh, Ph.D. as Senior Director, US Business Development.
Ted received a B.A. degree in chemistry from Yale University, and a Ph.D. degree from Harvard University, also in chemistry. Prior to joining Biovica, Ted worked as a medicinal chemist at Glaxo. Following this, he worked in drug discovery research at Eisai Inc, where he took on various interdisciplinary management and leadership roles for units in the U.S. and Japan, advancing drug discovery in the areas of oncology, inflammation and neurodegenerative disease. With over 20 years of experience in pharmaceutical research, Ted will be key for Biovica to increase the number of US collaboration partners and expand the ongoing trial programs for DiviTum, addressing applications as a predictive and response biomarker for cell-cycle regulating drugs.